http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3204002-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79b5c9de25a487b5300e061b0b05942
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
filingDate 2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9581f44b8b02c0313c25070d2558f28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1419c28bdd8818d770a3a8d68f181ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_371e6b9b876248db286ab006b17ac336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a9642cdb5abdafe6f6a5c0ca08fcc38
publicationDate 2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3204002-A1
titleOfInvention Pharmaceutical combination for the treatment of tumors
abstract The invention concerns a combination comprising at least one 2-oxo-indole derivative of formula (I) in which R 1 is selected from the group consisting of thienyl, imidazolyl and pyridyl, optionally substituted by (C 1 -C 3 ) alkyl, A is a -CH 2 CO- o -SO 2 - group; R is selected from the group consisting of 6,7-dimethoxy-1,2,3,4- tetrahydroisoquinolinyl, 3,4-dimethoxy-benzylamino, (C 1 -C 3 )alkyl, benzyl or a pharmaceutically acceptable salt thereof and at least one antitumor drug. The combination is for use in the treatment of tumors, in particular glioblastoma multiforme (GBM), breast tumor and pancreatic tumor. The combination is effective in the treatment of resistant tumor forms.
priorityDate 2014-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316654950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72725138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121272863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226496867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121272861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID321710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121272827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2773213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231441249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226452765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22571140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316654907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17904787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16820458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316654948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121272820
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316654922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316654914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121272835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316654909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226517840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316654957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121272822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409239

Total number of triples: 76.